Welcome to LookChem.com Sign In|Join Free
  • or
3-Methyl-5-nitro-1H-indole is a chemical compound characterized by its molecular formula C9H8N2O2. It is a yellow crystalline solid with a molecular weight of 176.17 g/mol. 3-Methyl-5-nitro-1H-indole is recognized for its strong odor and should be handled with appropriate safety measures.

61861-88-9

Post Buying Request

61861-88-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

61861-88-9 Usage

Uses

Used in Pharmaceutical Industry:
3-Methyl-5-nitro-1H-indole is utilized as a building block for the synthesis of various organic compounds. Its role in the creation of pharmaceuticals is significant due to its potential biological activities, which include anti-tumor and anti-inflammatory properties.
Used in Agrochemical Industry:
In the agrochemical sector, 3-Methyl-5-nitro-1H-indole serves as a key component in the synthesis of different organic compounds. Its application is crucial for developing new agrochemical products that can address various agricultural needs.

Check Digit Verification of cas no

The CAS Registry Mumber 61861-88-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,1,8,6 and 1 respectively; the second part has 2 digits, 8 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 61861-88:
(7*6)+(6*1)+(5*8)+(4*6)+(3*1)+(2*8)+(1*8)=139
139 % 10 = 9
So 61861-88-9 is a valid CAS Registry Number.

61861-88-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-Methyl-5-nitro-1H-indole

1.2 Other means of identification

Product number -
Other names 3-HYDROXY-4-NITRO-1H-INDAZOLE

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:61861-88-9 SDS

61861-88-9Relevant academic research and scientific papers

A Preclinical Candidate Targeting Mycobacterium tuberculosis KasA

Ahn, Yong-Mo,Alland, David,Awasthi, Divya,Capodagli, Glenn C.,Connell, Nancy,Freundlich, Joel S.,Grady, Courtney,Ho Liang, Hsin Pin,Inoyama, Daigo,Jadhav, Ravindra,Kumar, Pradeep,Li, Liping,Li, Shao-Gang,Mina, Marizel,Neiditch, Matthew B.,Park, Steven,Perlin, David S.,Richmann, Todd,Russo, Riccardo,Shrestha, Riju,Sukheja, Paridhi,Tsotetsi, Kholiswa,Wang, Xin,Zimmerman, Matthew,Dartois, Véronique

, p. 560 - 570 (2020/05/26)

Published Mycobacterium tuberculosis β-ketoacyl-ACP synthase KasA inhibitors lack sufficient potency and/or pharmacokinetic properties. A structure-based approach was used to optimize existing KasA inhibitor DG167. This afforded indazole JSF-3285 with a 30-fold increase in mouse plasma exposure. Biochemical, genetic, and X-ray studies confirmed JSF-3285 targets KasA. JSF-3285 offers substantial activity in an acute mouse model of infection and in the corresponding chronic infection model, with efficacious reductions in colony-forming units at doses as low as 5 mg/kg once daily orally and improvement of the efficacy of front-line drugs isoniazid or rifampicin. JSF-3285 is a promising preclinical candidate for tuberculosis. Inoyama et al. disclose the optimization of an indazole antitubercular targeting the β-ketoacyl-ACP synthase KasA. A structure-based approach has overcome significant issues with mouse metabolic stability and pharmacokinetics. A preclinical drug candidate has been delivered with efficacy in a mouse model of chronic M. tuberculosis infection at 5 mg/kg dosing.

FUSED TETRAZOLES AS LRRK2 INHIBITORS

-

Page/Page column 151-152, (2019/12/04)

The present invention is directed to fused tetrazoles of formula (IA) which are inhibitors of LRRK2 and are useful in the treatment of CNS disorders.

THERAPEUTIC INDOLES

-

, (2019/03/17)

The invention provides compounds of formula I and salts thereof wherein R1-R4 have any of the meanings described in the specification. The compounds are useful for treating bacterial infections (e.g. tuberculosis).

Diamine monomer containing N-pyrimidinyl indole structure and preparation method thereof

-

Paragraph 0130; 0131, (2018/03/24)

The invention discloses a diamine monomer containing an N-pyrimidinyl indole structure and a preparation method thereof. The preparation method specifically comprises the following steps of enabling a compound A, a nitrophenylboronic acid compound, silver trifluoroacetate and a catalyst [RhCp*C12]2 to react in methanol, so as to obtain a nitro compound B; under the protection of N2, dissolving the nitro compound B in dimethyl sulfoxide, under conditions of active iron powder and acetic acid, refluxing, and carrying out a reaction, and reducing nitro to amino, so that the diamine monomer C containing the N-pyrimidinyl indole structure is obtained. The diamine monomer containing the N-pyrimidinyl indole structure, which is provided by the invention, is simple in preparation method, easy in the control of a reaction process, further, is higher in yield, can be used as a diamine monomer for synthesizing polyimide, and has potential application values in special fields of high temperature resistance, flexible display substrates and the like.

Iridium-catalyzed methylation of indoles and pyrroles using methanol as feedstock

Chen, Shu-Jie,Lu, Guo-Ping,Cai, Chun

, p. 70329 - 70332 (2015/09/07)

Iridium-catalyzed methylation of indoles and pyrroles using methanol as the methylating agent was achieved. This transformation takes place via a borrowing hydrogen methodology under an air atmosphere, which constitutes a direct route to 3-methyl-indoles and methyl-pyrroles.

Regioselective hydroarylation reactions of C3 electrophilic N-acetylindoles activated by FeCl3: An entry to 3-(Hetero)arylindolines

Beaud, Rodolphe,Guillot, Regis,Kouklovsky, Cyrille,Vincent, Guillaume

supporting information, p. 7492 - 7500 (2014/06/23)

A method for the direct and rare umpolung of the 3 position of indoles is reported. The activation of N-acetylindole with iron(III) chloride allows the C-H addition of aromatic and heteroaromatic substrates to the C2-C3 double bond of the indole nucleus to generate a quaternary center at C3 and leads regioselectively to 3-arylindolines. Optimization, scope (50 examples), practicability (gram scale, air atmosphere, room temperature), and mechanistic insights of this process are presented. Synthetic transformations of the indoline products into drug-like compounds are also described.

Enamine rearrangement of pyridinium salts to indole ring: A combined experimental and molecular modeling study

Hosaan, Aisha,Fadda, Ahmed A.

, p. 638 - 644 (2013/07/19)

N-Alkyl pyridinium (II) and N-alkyl isoquinolinium salts V undergo cyclization reaction when heated with sodium bicarbonate to give the corresponding indolizine derivatives III and VI, respectively, which undergo ring opening and recyclization reactions when heated with aqueous sodium hydroxide to give the corresponding indole derivatives IV and IX, respectively. Molecular modeling tools including Molecular Mechanics using Augmented MM3 parameters followed by geometry optimization calculations in MO-G using PM3 parameters were performed to gain better understanding and more insights on the thermodynamic properties of the recyclization reactions of compounds IIa-g to the corresponding IIIa-g and IIIa-g to the corresponding IVa-g. The results were in excellent agreement with the experimental data and hence were proven to be a good tool in explaining different yields % because of the steric and electronic effects of electron-withdrawing groups on the reactivity of the pyridine ring for nucleophilic attack.

One-pot N-alkylation/Heck approach to substituted indoles

Weinrich, Melissa L.,Beck, Hilary P.

experimental part, p. 6968 - 6972 (2010/02/27)

Here, we report the palladium-catalyzed one-pot N-alkylation/Heck cyclization of anilines to substituted indoles employing Pd(OAc)2/XPhos. The scope and limitations of this methodology will be described.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 61861-88-9